| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $44.5M | -22.6% |
| Cost of Revenue | $18.6M | +3.8% |
| R&D Expense | $17.2M | -15.2% |
| SG&A Expense | $79.8M | +59.1% |
| Operating Income | -$71.1M | -130.9% |
| Pre-tax Income | -$83.8M | -89.8% |
| Income Tax | $0 | +100.0% |
| Net Income | -$83.8M | -89.8% |
| EPS (Basic) | -$0.78 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $17.8M | +141.9% |
| Inventory | $6.2M | +2.1% |
| Current Assets | $149.3M | +69.2% |
| Total Assets | $160.4M | +58.2% |
| Current Liabilities | $47.6M | +152.4% |
| Long-term Debt | $45.0M | +0.0% |
| Total Liabilities | $194.1M | +20.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$52.4M | -46.6% |
| Capital Expenditures | $562K | +253.5% |
| Investing Cash Flow | -$562K | -253.5% |
| Financing Cash Flow | $102.6M | +22.8% |
| Free Cash Flow | -$53.0M | -47.5% |
| -52.9% |
| EPS (Diluted) | -$0.78 | -52.9% |
| Stockholders' Equity |
| -$33.7M |
| +44.0% |